COURT-RULING ·Filed Sep 2, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 1/10
Horizonimmediate Processed28d 18h ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This ruling has no material effect on Teva's stock. The underlying employment case is routine and the discovery dispute is procedural. No further monitoring is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
TEVA ▲ +5.63% at T+20d
NEUTRAL call ✓ call won +5.63% · α vs SPY +5.96% · entry $37.49 → $39.60
Next anchor: T+60d in 8w
Entry anchored
Sep 1, 04:00 PM ET
via 1-min bar
T+1d
-2.32%
call -2.32% · α -3.37%
$36.62
settled 4w ago
T+5d
-3.04%
call -3.04% · α -2.08%
$36.35
settled 23d ago
T+20d
+5.63%
call +5.63% · α +5.96%
$39.60
settled 2d ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

The court denied a pro se plaintiff's appeal of a magistrate judge's order requiring her to appear in person for a deposition in an employment-related lawsuit against Teva Pharmaceuticals USA, Inc. This is a routine discovery dispute with no financial exposure or business impact on Teva.

Court Ruling Details

Ruling Date
Sep 2, 2026
Court
United States District Court for the District of New Jersey
Court Level
District
Judge
Susan D. Wigenton
Case Type
employment
Ruling Type
procedural
Outcome
WIN — ruling favors this company
Will It Be Appealed?
Unlikely
Precedent Risk
LOW

Key Facts

  • The ruling is a denial of a pro se plaintiff's appeal of a discovery order regarding deposition format.
  • The case involves a routine employment dispute with no stated damages or business impact.
  • No financial figures, injunctions, or material business consequences are mentioned in the ruling.

Financial Impact

No financial impact — the ruling concerns only the logistics of a deposition in a routine employment case.

Risk Factors

  • No material risks identified from this ruling.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-20eb76d5ec-TEVA
31 reports for TEVA
Performance horizon
100% Hit rate 9 of 9 directional calls best @ T+20▲ +17.61%Jul 20, 2026
Filters
Rows
Reports for TEVA — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Press Release
NEUTRAL ★ 5/10
$36.35 $39.19▲ +7.81%▲ +8.31%$39.29 (+8.09%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 5/10
$36.76 $39.25▲ +6.77%▲ +7.89%$39.29 (+6.88%)
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$37.49 $36.35▼ −3.04%▼ −2.08%$39.29 (+4.80%)
Aug 28, 2026
5w ago
Press Release
BULLISH ★ 6/10
$36.44 $36.36▼ −0.22%▼ −0.33%$39.29 (+7.82%)
Aug 25, 2026
5w ago
Court Ruling
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.14 $36.46▲ +0.89%▲ +0.93%$39.29 (+8.72%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.81 $36.45▲ +4.70%▲ +3.49%$39.29 (+12.87%)
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 7/10
$35.01 $35.36▲ +1.00%▼ −2.51%$39.29 (+12.23%)
Jul 29, 2026
9w ago
8-K
MIXED ★ 5/10
$34.71 $34.72▲ +0.03%▼ −5.50%$39.29 (+13.20%)
Showing 10 of 31

US Market Status

Market Open — Closes in 3h 40m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access